Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2024 Earnings Call Transcript
Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics' Call to discuss its First Quarter 2024 Financial Results and Business Updates.
Stay updated with breaking news from Gil Blum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics' Call to discuss its First Quarter 2024 Financial Results and Business Updates.
Operator: Good afternoon, ladies and gentlemen. And welcome the Celcuity First Quarter 2024 Financial Results Conference call. At this time, all lines are in a listen-only mode.
GERN earnings call for the period ending March 31, 2024.
AUSTIN, TX & DURHAM, NC, April 01, 2024 -- Shattuck Labs, Inc. , a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic...
Celcuity Inc. beats earnings expectations. Reported EPS is $-0.65, expectations were $-0.71.